follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

ADMA Biologics Inc. closes $26.5M IPO

By

Back to Top Comments Email Print

Ramsey-based ADMA Biologics Inc. announced Tuesday the closing of its previously announced initial public offering of 3.35 million shares of its common stock at a public offering price of $8.50 per share.

According to the announcement, aggregate net proceeds to ADMA, after deducting underwriting discounts and commissions, will be approximately $26.5 million. Oppenheimer & Co. acted as sole book-running manager for the offering, first priced last week. Ladenburg Thalmann & Co. Inc., Maxim Group LLC and Laidlaw & Co. Ltd. acted as co-managers.

 

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top